Metabolic

New Data on the Natural History of MoCD Type A at SSIEM Conference

BridgeBio Pharma, Inc, a subsidiary Origin Biosciences announced today the presentation of a study on the natural history of patients with Molybdenum Cofactor Deficiency (MoCD) and isolated sulfite oxidase deficiency (ISOD). The study was presented at the 2019 SSIEM Annual Symposium held in Rotterdam, Netherlands. In this comprehensive natural history...